Eleva Appoints Martin Bauer, MD as Chief Medical Officer Adding Substantial Clinical Development Expertise to the Organization
Eleva appoints Dr. Martin Bauer as CMO. Its Factor H (CPV - 104) program may enter clinic in 2025 for C3G, and dry AMD is a potential second indication.
February 20, 2025
by Biotech Newswire
Axel Klarmeyer Joins Chamlion as CEO, Chamlion International
Chamlionis pleased to announce the appointment of Axel Klarmeyer as the CEO of Chamlion International.
February 14, 2025
by PR Newswire
Touchlight Appoints Industry Leader Will Downie as Adviser to Support Strategic Growth in Synthetic DNA Platforms
Touchlight, a pioneer in synthetic DNA technology, appoints Will Downie as an adviser to support the strategic growth of its synthetic DNA platforms.
January 28, 2025
by PharmaSources
Marksans Pharma appoints Dr Meena Rani Surana as Independent Woman Director
She has about 27 years of experience in pharmaceutical regulatory affairs, quality assurance, formulation and pre-formulation.
September 7, 2020
by expresspharma
Symbiosis Appoints COO
Symbiosis Pharmaceutical Services has appointed John McCormick as chief operating officer and executive member of its Board of Directors.
August 27, 2020
by contractpharma
Abzena Appoints Senior Director of Manufacturing
Anu Bansal brings 20 years’ experience in the biopharmaceutical industry.
August 19, 2020
by contractpharma
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Bhattacharjee was previously President & CEO – Global Generic Medicines of Teva Pharmaceutical Industries.
August 18, 2020
by expresspharma
Avomeen Appoints Formulation, Manufacturing Head
Hashim Ahmed brings more than 25 years of experience from the biopharmaceutical and CDMO industries.
July 17, 2020
by contractpharma
Rockwell Medical Announces Board of Directors Appointment
Rockwell Medical announced the appointment of Russell H. Ellison, MD, MSc, to its Board of Directors, effective January 9, 2020. Dr. Ellison has held leadership positions in both emerging biotechnology and large pharmaceutical companies for more than four
January 16, 2020
by americanpharmaceuticalreview
Vyome Announces Executive Management Appointment
Vyome Therapeutics announced the appointment of Craig Tooman as the Chief Operating Officer (COO) and Chief Financial Officer (CFO). Tooman brings more than 25 years of operating, financial, and M&A experience in the biotechnology and pharmaceutical indus
January 13, 2020
by americanpharmaceuticalreview
AzurRx BioPharma Announces Appointment of Daniel Schneiderman as Chief Financial Officer
AzurRx BioPharma, Inc. (NASDAQ: AZRX) ("AzurRx" or the "Company"), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that Daniel Schneiderman has been appointed to serve as the
January 5, 2020
by firstwordpharma
Accellix Announces Board of Directors Appointment
Accellix announces the appointment of a new Board Member, Charles (Chuck) Piazza.
August 16, 2019
by americanpharmaceuticalreview